Asahi Group Holdings would begin making minority investments in US start-ups from January 2023 through its Asahi Group Beverages & Innovation Fund which will open up new markets for low-alcohol and non-alcohol beverages.
The fund will support US start-ups that have "attractive brands" with significant future growth potential in the non-alcoholic beer-taste beverages, adult soft drink beverages, and low-alcohol categories.
It would also support start-ups with technology that leads to new sales and manufacturing methods, according to Atsushi Katsuki, president and CEO of Asahi Group Holdings.
Asahi will use its business platform to encourage sales growth for the goods and services offered by such enterprises both domestically and internationally.
By the end of 2025, the total investment is anticipated to be around $70 million. Employees recruited from the regional headquarters of Asahi Group will serve as the investment managers for Asahi Group Beverages & Innovation.


Britain has almost 1 million young people not in work or education – here’s what evidence shows can change that
Home ownership is slipping out of reach. It’s time to rethink our fear of ‘forever renting’
India Budget 2026: Modi Government Eyes Reforms Amid Global Uncertainty and Fiscal Pressures
Wall Street Slides as Warsh Fed Nomination, Hot Inflation, and Precious Metals Rout Shake Markets
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
How the UK’s rollback of banking regulations could risk another financial crisis
Russia Stocks End Flat as MOEX Closes Unchanged Amid Mixed Global Signals
JPMorgan Lifts Gold Price Forecast to $6,300 by End-2026 on Strong Central Bank and Investor Demand
Debate over H-1B visas shines spotlight on US tech worker shortages
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Tech Stocks Rally in Asia-Pacific as Dollar Remains Resilient
Ferrari Group to Launch IPO in Amsterdam, Targets Over $1 Billion Valuation
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations 



